Search

everythinglearnresearchcommunity

for

Search:↓

Many elderly women experience unwanted facial hair and various hair loss conditions, with treatments available for each condition.

Hirsutism in women is often due to hormone sensitivity and has significant psychological effects.

Removing both ovaries can treat increased testosterone and related symptoms in postmenopausal women with ovarian hyperthecosis.

Menopause reduces skin fat, but treatments like magnolol and PLLA-SCA can help restore skin health.

The document concludes that a systematic approach is crucial to identify causes of androgen excess in women beyond the most common cause, Polycystic ovary syndrome (PCOS).

Hirsutism in women often indicates a hormonal imbalance and can be managed with a combination of hormonal treatments and hair removal methods.

Most patients with frontal fibrosing alopecia are middle-aged women, often have thyroid disease, and some treatments can help stabilize the condition.

Women with hyperandrogenic amenorrhea have similar bone density to healthy women but lower than androgenized women without amenorrhea, and high DHEAS levels might affect bone density.

Brothers of women with PCOS tend to have higher levels of a hormone called DHEAS, indicating a possible genetic link.

Women with PCOS often have liver disease, so liver health checks are important for them.

The woman's skin and hair symptoms were confirmed as frontal fibrosing alopecia, and while facial papules are common in such cases, there's no effective local treatment, but systemic treatments can help.

Women with PCOS have more depression and stress due to high androgen levels, not obesity or insulin resistance.

Most women lack knowledge about androgens and their excess symptoms.

Women with PCOS have higher xanthine oxidase activity linked to inflammation and heart disease risks.

Using 3% topical minoxidil can help women with hair loss, but more research is needed.

PCOS affects women's health by increasing the risk of diabetes, heart disease, and reproductive issues.

Combination therapy with oral contraceptives and spironolactone improves hair growth, menstrual issues, and acne in women with PCOS.

Many women with PCOS have abnormal cholesterol levels, needing careful management.

A young woman had a rare, aggressive ovarian tumor that was hard to diagnose and treat, leading to disease progression despite treatment.

Women with scarring alopecia are less likely to have used hormone replacement therapy or oral contraceptives compared to those with female pattern hair loss.

A woman's health issues were caused by arsenic poisoning from kelp supplements.

Hair loss in women is genetic, diagnosed by examination and biopsy, and treated with minoxidil, finasteride, or transplantation.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

Over 50% of women over 50 experience hair loss, with minoxidil being the only proven effective treatment.

Testosterone therapy can help women with androgen deficiency by improving energy, sex drive, and bone health with few side effects.

Testosterone's role in women's sex drive is unclear and needs more research, as low levels don't always mean less sexual interest and high levels can cause side effects.

About 7% to 15% of Iranian women have polycystic ovary syndrome, depending on the criteria used to diagnose it.

Hormonal treatment is effective for women with acne not helped by usual treatments, especially if they have hormonal imbalances.

The document says that hair loss in women is often due to androgenic alopecia, similar to male baldness, and that hirsutism is treated with hormonal and cosmetic methods.

Most women with excess hair growth have an underlying hormonal issue, often treated with medication and hair removal methods.